Abstract
Bleomycin has, in the years of developing electrochemotherapy (ECT), proven to be an extremely potent drug for this cancer treatment modality and is also the most frequently applied chemical agent. It is of importance to investigate the pharmacokinetics of bleomycin under normal conditions and particularly in combination with ECT.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Crooke, S. T. (1983) Pharmacokinetics of Anticancer Agents in Humans (Ames, M. M., Powis, G., and Kocach, J. S., eds.), Elsevier Science, Amsterdam, pp. 279–290.
Thakur, M. L. (1973) The preparation of indium-111 labelled bleomycin for tumor localisation. Int. J. Appl. Radiat. Isot. 24, 357–359.
Hou, D. Y., and Yosh, M. (1992) Distribution of 111In-bleomycin complex in small cell lung cancer cells by autoradiography. J. Surg. Oncol. 49, 93–97.
Hou, D. Y., Hoch, H., Johnston, G. S., Tsou, K. C., Farkas, R. J., and Miller, E. E. (1983) Stability of 111In-bleomycin in vivo: properties compared with 57Co-bleomycin. Eur. J. Nucl. Med. 8, 535–540.
Hou, D. Y., Hoch, H., Johnston, G. S., Tsou, K. C., Jones, A. E., Miller, E. E., and Larson, S. M. (1984) A new tumor imaging agent-111In-bleomycin complex: Comparison with 67-Ga-citrate and 57-Co-bleomycin in tumor-bearing animals. J. Surg. Oncol. 27, 189–195.
Siesjö, P., Visse, E., Lindvall, M., Salford, L. G., and Sjögren, H.-O. (1993) Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts. Cancer Immunol. Immunother. 37, 67–74.
Hou, D. Y., Hoch, H., Johnston, G. S., Tsou, K. C., Jones, A. E., Farkas, R. J., Miller, E. E., and Larson, S. M. (1985) A new 111-In-bleomycin complex for combined radiotherapy and chemotherapy. J. Surg. Oncol. 29, 91–98.
Woods, J. S. and Fowler, B. A. (1982) Selective inhibition of delta-aminolevulinic acid dehydratase by indium chloride in rat kidney: Biochemical and ultrastructural studies. Exp. Mol. Pathol. 36, 306–315.
Serša, G., Čemažar, M., and Miklavčič, D. (1995) Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55, 3450–3455.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Engström, P., Salford, L.G., Persson, B.R.R. (2000). Distribution of Bleomycin in a Rat Model. In: Jaroszeski, M.J., Heller, R., Gilbert, R. (eds) Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Methods in Molecular Medicine, vol 37. Humana Press. https://doi.org/10.1385/1-59259-080-2:285
Download citation
DOI: https://doi.org/10.1385/1-59259-080-2:285
Publisher Name: Humana Press
Print ISBN: 978-0-89603-606-2
Online ISBN: 978-1-59259-080-3
eBook Packages: Springer Protocols